Učitavanje...

Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Ther
Glavni autori: Evans, Marc, Dejager, Sylvie, Schweizer, Anja, Foley, James E.
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4374076/
https://ncbi.nlm.nih.gov/pubmed/25783754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0104-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!